The Effect of Zinc Supplementation in Humans on Plasma Lipids, Antioxidant Status and Thrombogenesis

Journal of the American College of Nutrition

Volumn 25, Issue 4, 2006, Pages 285-291

  Hughes, Suzanne ^a   Samman, Samir ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Antioxidants; Cholesterol; Haemostasis; Heart disease; Humans; Lipids; Zinc

Indexed keywords

ANTIOXIDANT; CHOLESTEROL; COPPER; COPPER ZINC SUPEROXIDE DISMUTASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; ZINC;

ANTIOXIDANT ACTIVITY; ATHEROGENESIS; ATHEROSCLEROSIS; BLEEDING TIME; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; CIRCADIAN RHYTHM; DIET SUPPLEMENTATION; DIETARY INTAKE; HEMOSTASIS; HUMAN; INCIDENCE; ISCHEMIC HEART DISEASE; LIFESTYLE; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; NUTRITIONAL STATUS; REVIEW; THROMBOCYTE AGGREGATION; THROMBOGENESIS; TRIACYLGLYCEROL BLOOD LEVEL; ZINC BLOOD LEVEL; ZINC DEFICIENCY;

ANTIOXIDANTS; CHOLESTEROL, HDL; CORONARY DISEASE; DIETARY SUPPLEMENTS; HUMANS; LIPIDS; RANDOMIZED CONTROLLED TRIALS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUPEROXIDE DISMUTASE; THROMBOSIS; TRACE ELEMENTS; ZINC;

EID: 33748797666     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2006.10719537     Document Type: Article

References (82)

1. Samman S: Zinc and copper. In Mann JI, Truswell AS (eds): "Essentials of Human Nutrition," 2nd ed. New York: Oxford University Press, pp 159-166, 2002.
2. Prasad AS: Clinical, biochemical and nutritional spectrum of zinc deficiency in human subjects: an update. Nutr Rev 41: 197-208, 1983.
3. Truswell AS: "ABC of Nutrition," 4th ed. London: BMJ, 2003.
4. Strain JJ: Trace elements and cardiovascular disease. Bibl Nutr Dieta 54: 127-140, 1998.
5. Falkiewicz B, Dabrowska E, Lukasiak J, Cajzer D, Jablonska-Kaszewska I: Zinc deficiency and normal contents of magnesium and calcium in metabolic X syndrome patients as assessed by the analysis of hair element concentrations. Biofactors 11: 139-141, 2000.
6. Martin-Lagos F, Navarro-Alarcon M, Terres-Martos C, Lopez-G de la Serena H, Lopez-Martinez MC: Serum copper and zinc concentrations in serum from patients with cancer and cardiovascular disease. Sci Total Env 204: 27-35, 1997.
7. Reunanen A, Knekt P, Marniemi J, Maki J, Maatela J, Aromaa A: Serum calcium, magnesium, copper and zinc and risk of cardiovascular death. Eur J Clin Nutr 50: 431-437, 1996.
8. Oster O, Dahm M, Oelert H, Prellwitz W: Concentrations of some trace elements (Se, Zn, Cu, Fe, Mg, K) in blood and heart tissue of patients with coronary heart disease. Clin Chem 35: 851-856, 1989.
9. Speich M, Gelot S, Arnaud P, Nicolas G: Changes in magnesium, zinc, calcium, potassium, cholesterol, and creatine kinase concentrations in patients from pre-infarction syndrome to fatal myocardial infarction. Clin Chem 34: 2083-2086, 1988.
10. Martin-Moreno JM, Gorgojo L, Riemersma RA, Gomez-Aracena J, Kark JD, Guillen J, Jimenez J, Ringstad JJ, FernandezCrehuet J, Bode P, Kok FJ, Heavy M, for the Heavy Metals and Myocardial Infarction Study Group: Myocardial infarction risk in relation to zinc concentration in toenails. Br J Nutr 89: 673-678, 2003.
11. Khan SN, Rahman MA, Samad A: Trace elements in serum from Pakistani patients with acute and chronic ischemic heart disease and hypertension. Clin Chem 30: 644-648, 1984.
12. Iskra M, Patelski J, Majewski W: Concentrations of calcium, magnesium, zinc and copper in relation to free fatty acids and cholesterol in serum of atherosclerotic men. J Trace Elem Electrolytes Health Dis 7: 185-188, 1993.
13. Tiber AM, Sakhaii M, Joffe CD, Ratnaparkhi MV: Relative value of plasma copper, zinc, lipids and lipoproteins as markers for coronary artery disease. Atheroscl 62: 105-110, 1986.
14. Mielcarz G, Howard AN, Mielcarz B, Williams NR, Rajput-Williams J, Nigdigar SV, Stone DL: Leucocyte copper, a marker of copper body status is low in coronary artery disease. J Trace Elem Med Biol 15: 31-35, 2001.
15. Iskra M, Patelski J, Majewski W: Relationship of calcium, magnesium, zinc and copper concentrations in the arterial wall and serum in atherosclerosis obliterans and aneurysm. J Trace Elem Med Biol 11: 248-252, 1997.
16. Piorunska-Stolzmann M, Iskra M, Patelski J, Majewski W: Serum glycerol ester hydrolase activity is related to zinc and copper concentrations in atherosclerosis obliterans and aneurysm. J Trace Elem Med Biol 12: 39-43, 1988.
17. Bialkowska M, Hoser A, Szostak WB, Dybczynski R, Sterlinski S, Nowicka G, Majchrzak J, Kaczorowski J, Danko B: Hair zinc and copper concentration in survivors of myocardial infarction. Ann Nutr Metab 31: 327-332, 1987.
18. Singh RB, Niaz MA, Rastogi SS, Bajaj S, Gaoli Z, Shoumin Z: Current zinc intake and risk of diabetes and coronary artery disease and factors associated with insulin resistance in rural and urban populations of North India. J Am Coll Nutr 17: 564-570, 1998.
19. Bjorksten F, Aromaa A, Knekt P, Malinen L: Serum zinc concentrations in Finns. Acta Med Scan 204: 67-74, 1987.
20. McMaster D, McCrum E, Patterson CC, Kerr M McF, O'Reilly D, Evans AE, Love AHG: Serum copper and zinc in random samples of the population of Northern Ireland. Am J Clin Nutr 56: 440-446, 1992.
21. Thijs L, Staessen J, Amery A, Bruaux P, Buchet J-P, Claeys F, De Plaen P, Ducoffre G, Lauwerys R, Lijnen P, Nick L, Remy AS, Roels H, Rondia D, Sartor F: Determinants of serum zinc in a random population sample of four Belgian towns with different degrees of environmental exposure to cadmium. Env Health Pers 98: 251-258, 1992.
22. Kok FJ, Van Duijn CM, Hofman A, Van der Voet GB, De Wolff FA, Paays CH, Valkenburg HA: Serum copper and zinc and the risk of death from cancer and cardiovascular disease. Am J Epidemiol 128: 352-359, 1988.
23. Menditto A, Morisi G, Alimonti A, Caroli S, Petrucci F, Spagnolo A, Menotti A, and the NFR Study Group: Association of serum copper and zinc with serum electrolytes and with selected risk factors for cardiovascular disease in men aged 55-75 years. J Trace Elem Electrolytes Health Dis 7: 251-253, 1993.
24. Hiller R, Seigel D, Sperduto RD, Blair N, Burton TC, Farber MD, Gragoudas ES, Gunter EW, Haller J, Seddon JM, Sowell AL, Yannuzzi LA and The Eye Disease Case-control Study Group: Serum zinc and serum lipid profiles in 778 adults. Ann Epidemiol 5: 490-496, 1995.
25. The Age-Related Eye Disease Study Research Group: The effect of five-year zinc supplementation on serum zinc, serum cholesterol and hematocrit in persons randomly assigned to treatment group in the age-related eye disease study: AREDS Report No. 7. J Nutr 132: 697-702, 2002.
26. Kromhout D, Wibowo AA, Herber RF, Dalderup LM, Heerdink H, de Lezenne Coulander C, Zielhuis RL: Trace metals and coronary heart disease risk indicators in 152 elderly men (the Zutphen Study). Am J Epidemiol 122: 378-385, 1985.
27. Fischer PW, Collins MW: Relationship between serum zinc and copper and risk factors associated with cardiovascular disease. Am J Clin Nutr 34: 595-597, 1981.
28. Mezzetti A, Pierdomenico SD, Costantini F, Romano F, De Cesare D, Cuccurullo F, Imbastaro T, Riario-Sforza G, Di Giacomo F, Zuliani G, Fellin R: Copper/zinc ratio and systemic oxidant load: effect of aging and aging-related degenerative diseases. Free Rad Biol Med 25: 676-681, 1998.
29. He J, Tell GS, Tang Y-C, Mo P-S, He G-Q: Relation of serum zinc and copper to lipids and lipoproteins: the Yi People Study. J Am Coll Nutr 11: 74-78, 1992.
30. Medeiros D, Pellum L, Brown B: Serum lipids and glucose as associated with hemoglobin concentrations and copper and zinc intake in young adults. Life Sci 32: 1897-1904, 1983.
31. Bogden JD, Oleske JM, Lavenhar MA, Munves EM, Kemp FW, Bruening KS, Holding KJ, Denny TN, Guarino MA, Krieger LM, Holland BK: Zinc and immunocompetence in elderly people: effects of zinc supplementation for 3 months. Am J Clin Nutr 48: 655-663, 1988.
32. Gatto LM, Samman S: The effect of zinc supplementation on plasma lipids and low-density lipoprotein oxidation in males. Free Rad Biol Med 19: 517-521, 1995.
33. Samman S, Roberts DCK: The effect of zinc supplements on lipoproteins and copper status. Atheroscl 70: 247-252, 1988.
34. Fortes C, Agabiti N, Fano V, Pacifici R, Forastiere F, Virgili F, Zuccaro P, Perruci CA, Ebrahim S: Zinc supplementation and plasma lipid peroxides in an elderly population. Eur J Clin Nutr 51: 97-101, 1997.
35. Chandra RK: Excessive intake of zinc impairs immune responses. J Am Med Assoc 252: 1443-1446, 1984.
36. Hooper PL, Visconti L, Garry PJ, Johnson GE: Zinc lowers highdensity lipoprotein-cholesterol concentrations. J Am Med Assoc 244: 1960-1961, 1980.
37. Crouse SF, Hooper PL, Atterbom HA, Papenfuss RL: Zinc ingestion and lipoprotein values in sedentary and endurance-trained men. J Am Med Assoc 252: 785-787, 1984.
38. Black MR, Medeiros DM, Brunett E, Welke R: Zinc supplements and serum lipids in young adult white males. Am J Clin Nutr 47: 970-975, 1988.
39. Bonham M, O'Connor JM, McAnena LB, Walsh PM, Downes CS, Hannigan BM, Strain JJ: Zinc supplementation has no effect on lipoprotein metabolism, hemostasis, and putative indices of copper status in healthy men. Biol Tr Elem Res 93: 75-86, 2003.
40. Milne DB, Davis CD, Nielsen FH: Low dietary zinc alters indices of copper function and status in postmenopausal women. Nutr 17: 701-708, 2001.
41. Boukaiba N, Flament C, Acher S, Chappuis P, Piau A, Fusselier M, Dardenne M, Lemonnier D: A physiological amount of zinc supplementation: effects on nutritional, lipid, and thymic status in an elderly population. Am J Clin Nutr 57: 566-572, 1993.
42. Goodwin JS, Hunt WC, Hooper P, Garry PJ: Relationship between zinc intake, physical activity, and blood concentrations of highdensity lipoprotein cholesterol in a healthy elderly population. Metab Clin Exp 34: 519-523, 1985.
43. Samman S, Roberts DCK: The effect of zinc supplements on plasma zinc and copper concentrations and the reported symptoms in healthy volunteers. Med J Aust 146: 246-249, 1987.
44. Pachotikarn C, Medeiros DM, Windham F: Effect of oral zinc supplementation upon plasma, lipids, blood pressure, and other variables in young adult white males. Nutr Rep Int 32: 373-382, 1985.
45. Freeland-Graves JH, Friedman BJ, Han WH, Shorey RL, Young R: Effect of zinc supplementation on plasma high-density lipoprotein cholesterol and zinc. Am J Clin Nutr 35: 988-992, 1982.
46. Age-Related Eye Disease Study Research Group: A randomised, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. AREDS Report No. 8. Arch Opthamol 119: 1417-1436, 2001.
47. Marx G, Eldor A: The procoagulant effect of zinc on fibrin clot formation. Am J Hematol 19: 151-159, 1985.
48. Baird TR, Walsh PN: Activated platelets but not endothelial cells participate in the initiation of the consolidation phase of blood coagulation. J Biol Chem 277: 28498-24503, 2002.
49. Greengard JS, Heeb MJ, Ersdal E, Walsh PN, Griffin JH: Binding of coagulation factor XI to washed human platelets. Biochem 25: 3884-3890, 1986.
50. Mahdi F, Madar ZS, Figueroa CD, Schmaier AH: Factor XII interacts with the multiprotein assembly of urokinase plasminogen activator receptor, gC1qR, and cytokeratin 1 on endothelial cell membranes. Blood 99: 3585-3596, 2002.
51. Zhao Y, Qiu Q, Mahdi F, Shariat-Madar Z, Rojkjaer R, Schmaier AH: Assembly and activation of HK-PK complex on endothelial cells results in bradykinin liberation and NO formation. Am J Physiol 280: H1821-H1829, 2001.
52. Gorodetsky R, Mou X, Blankenfeld A, Marx G: Platelet multielemental composition, lability, and subcellular localization. Am J Hematol 42: 278-283, 1993.
53. Marx G, Korner G, Mou X, Gorodetsky R: Packaging zinc, fibrinogen, and factor XIII in platelet alpha-granules. J Cell Physiol 156: 437-442, 1993.
54. Schousboe I: Binding of activated Factor XII to endothelial cells affects its inactivation by the C1-esterase inhibitor. Eur J Biochem 268: 3958-3963, 2001.
55. Marx G, Krugliak J, Shaklai M: Nutritional zinc increases platelet reactivity. Am J Hematol 38: 161-165, 1991.
56. Ruz M, Cavan KR, Bettger WJ, Gibson RS: Erythrocytes, erythrocyte membranes, neutrophils and platelets as biopsy materials for the assessment of zinc status in humans. Br J Nutr 68: 515-527, 1992.
57. Swanson CA, Mansourian R, Dirren H, Rapin CH: Zinc status of healthy elderly adults: response to supplementation. Am J Clin Nutr 48: 343-349, 1988.
58. O'Dell BL: Role of zinc in plasma membrane function. J Nutr 130: 1432S-1436S, 2000.
59. Gordon PR, Woodruff CW, Anderson HL, O'Dell BL: Effect of acute zinc deprivation on plasma zinc and platelet aggregation in adult males. Am J Clin Nutr 35: 113-119, 1982.
60. Halliwell B, Gutteridge JMC: "Free Radicals in Biology and Medicine," 3rd ed. Oxford: Oxford University Press: 1999.
61. Zou MH, Shi C, Cohen RA: Oxidation of the zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109: 817-826, 2002.
62. Bray TM, Bettger WJ: The physiological role of zinc as an antioxidant. Free Rad Biol Med 8: 281-291, 1990.
63. Powell SR: The antioxidant properties of zinc. J Nutr 130: 1447S-1454S, 2000.
64. Ruz M, Cavan KR, Bettger WJ, Fischer PW, Gibson RS: Indices of iron and copper status during experimentally induced, marginal zinc deficiency in humans. Biol Tr Elem Res 34: 197-212, 1992.
65. Cousins RJ: Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. Physiol Rev 65: 238-309, 1985.
66. Strain JJ: Newer aspects of micronutrients in chronic disease: copper. Proc Nutr Soc 53: 583-598, 1994.
67. Dubick MA, Hunter GC, Casey SM, Keen CL: Aortic ascorbic acid, trace elements, and superoxide dismutase activity in human aneurysmal and occlusive disease. Proc Soc Exp Biol Med 184: 138-143, 1987.
68. Samman S: Dietary versus cellular zinc: the antioxidant paradox. Free Radic Biol Med 14: 95-96, 1993.
69. Yadrick MK, Kenney MA, Winterfeldt EA: Iron, copper, and zinc status: response to supplementation with zinc or zinc and iron in adult females. Am J Clin Nutr 49: 145-150, 1989.
70. Abdallah SM, Samman S: The effect of increasing dietary zinc on the activity of superoxide dismutase and zinc concentration in erythrocytes of healthy female subjects. Eur J Clin Nutr 47: 327-332, 1993.
71. Girodon F, Blache D, Monget AL, Lombart M, Brunet-Lecompte P, Arnaud J, Richard MJ, Galan P: Effect of a two-year supplementation with low doses of antioxidant vitamins and/or minerals in elderly subjects on concentrations of nutrients and antioxidant defense parameters. J Am Coll Nutr 16: 357-365, 1997.
72. Galan P, Preziosi P, Monget AL, Richard MJ, Arnaud J, Lesourd B, Girodon F, Alferez MJ, Bourgeois C, Keller H, Favier A, Hercberg S: Effects of trace element and/or vitamin supplementation on vitamin and mineral status, free radical metabolism and immunological markers in elderly long term-hospitalized subjects. Geriatric Network MIN. VIT. AOX. Int J Vit Nutr Res 67: 450-460, 1997.
73. Fischer PW, Giroux A, L'Abbe MR: Effect of zinc supplementation on copper status in adult man. Am J Clin Nutr 40: 743-746, 1984.
74. Davis CD, Milne DB, Nielsen FH: Changes in dietary zinc and copper affect zinc-status indicators of postmenopausal women, notably, extracellular superoxide dismutase and amyloid precursor proteins. Am J Clin Nutr 71: 781-788, 2000.
75. Preziosi P, Galan P, Herbeth B, Valeix P, Roussel AM, Malvy D, Paul-Dauphin A, Arnaud J, Richard MJ, Briancon S, Favier A, Hercberg S: Effects of supplementation with a combination of antioxidant vitamins and trace elements, at nutritional doses, on biochemical indicators and markers of the antioxidant system in adult subjects. J Am Coll Nutr 17: 244-249, 1988.
76. Paik HY, Joung H, Lee JY, Lee HK, King JC, Keen CL: Serum extracellular superoxide dismutase activity as an indicator of zinc status in humans. Biol Tr Elem Res 69: 45-57, 1999.
77. Iskra M, Majewski W: Copper and zinc concentrations and the activities of ceruloplasmin and superoxide dismutase in atherosclerosis obliterans. Biol Trace Element Res 73: 55-65, 2000.
78. Cousins RJ, Blanchard RK, Popp MP, Liu L, Cao J, Moore JB, Green CL: A global view of the selectivity of zinc deprivation and excess on genes expressed in human THP-1 mononuclear cells. Proc Nat Acad Sci (USA) 100: 6952-6957, 2003.
79. Moore JB, Blanchard RK, Cousins RJ: Dietary zinc modulates gene expression in murine thymus: results from a comprehensive differential display screening. Proc Nat Acad Sci (USA) 100: 3883-3888, 2003.
80. Blanchard RK, Cousins RJ: Differential display of intestinal mRNAs regulated by dietary zinc. Proc Nat Acad Sci (USA) 93: 6863-6868, 1996.
81. tom Dieck H, Doring F, Roth HP, Daniel H: Changes in rat hepatic gene expression in response to zinc deficiency as assessed by DNA arrays. J Nutr 133: 1004-1010, 2003.
82. Beattie JH, Kwun I-S: Is zinc deficiency a risk factor for atherosclerosis? Br J Nutr 91: 177-181, 2004.